FDA clears 6 more doses of Hospira's heparin

09/1/2009 | Forbes

The FDA is allowing Hospira to market six additional doses and concentrations of blood thinner heparin. The products will be available in three single-dose vials and three multiple-dose vials.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC